| abstract |
A composition comprising (i) a prepograstrin peptide precursor gene and (ii) an EGF receptor ligand gene capable of being stably introduced into pancreatic cells such that their expression can stimulate pancreatic islet precursor cells for use in a method of treatment of diabetes mellitus. |